Rhabdomyoblastic Differentiation in Metastatic Melanoma: Making Sense of a Rare but Complex Form of Mimicry

被引:14
作者
Reilly, Daniel J. [1 ]
Volchek, Mila [1 ]
Ting, Jeannette W. C. [1 ]
Allan, Prue [1 ]
Findlay, Michael W. [1 ,2 ,3 ]
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Stanford Univ, Stanford, CA 94305 USA
关键词
melanoma; tumor differentiation; rhabdoid tumor; rhabdomyoblastic; MALIGNANT RHABDOID TUMOR; ULTRASTRUCTURAL EVIDENCE; RHABDOMYOSARCOMA; FEATURES; CANCER; ORIGIN;
D O I
10.1177/1066896913510031
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A case of melanoma with rhabdomyoblastic differentiation is presented in the context of the previously reported cases. The emerging literature seeking to identify the molecular basis of rhabdoid and rhabdomyoblastic differentiation, as well as their poor prognosis, is reviewed. The combination of a diverse range of morphology and the potential for spontaneous primary tumor regression, despite metastasis, makes the accurate diagnosis of melanoma challenging. Histopathology review is often recommended in these cases, as is referral to a specialized cancer center for discussion in a multidisciplinary meeting. Improved recognition of this rare pattern of melanoma morphology may provide the means for omics-based techniques to identify novel therapeutic targets to improve the prognostic outlook for these patients.
引用
收藏
页码:520 / 524
页数:5
相关论文
共 21 条
[1]  
Banerjee SS, 2000, HISTOPATHOLOGY, V36, P387
[2]   MALIGNANT RHABDOID TUMOR OF THE CENTRAL-NERVOUS-SYSTEM [J].
BIGGS, PJ ;
GAREN, PD ;
POWERS, JM ;
GARVIN, AJ .
HUMAN PATHOLOGY, 1987, 18 (04) :332-337
[3]   METASTATIC MALIGNANT-MELANOMA SHOWING A RHABDOID PHENOTYPE - FURTHER EVIDENCE OF A NONSPECIFIC HISTOLOGICAL PATTERN [J].
BITTESINI, L ;
TOS, APD ;
FLETCHER, CDM .
HISTOPATHOLOGY, 1992, 20 (02) :167-170
[4]   Vemurafenib: the first drug approved for BRAF-mutant cancer [J].
Bollag, Gideon ;
Tsai, James ;
Zhang, Jiazhong ;
Zhang, Chao ;
Ibrahim, Prabha ;
Nolop, Keith ;
Hirth, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (11) :873-886
[5]   Primary malignant melanoma with rhabdoid features: A histologic and immunocytochemical study of three cases [J].
Borek, BT ;
McKee, PH ;
Freeman, JA ;
Maguire, B ;
Brander, WL ;
Calonje, E .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1998, 20 (02) :123-127
[6]   MALIGNANT RHABDOID TUMOR OF THE BLADDER WITH IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL EVIDENCE SUGGESTING HISTIOCYTIC ORIGIN [J].
CARTER, RL ;
MCCARTHY, KP ;
ALSAM, SZ ;
MONAGHAN, P ;
AGRAWAL, M ;
MCELWAIN, TJ .
HISTOPATHOLOGY, 1989, 14 (02) :179-190
[7]   MALIGNANT RHABDOID TUMOR OF THE UTERUS - AN IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY [J].
CATTANI, MG ;
VIALE, G ;
SANTINI, D ;
MARTINELLI, GN .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 420 (05) :459-462
[8]   METASTATIC MALIGNANT-MELANOMA WITH RHABDOID FEATURES [J].
CHANG, ES ;
WICK, MR ;
SWANSON, PE ;
DEHNER, LP .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (04) :426-431
[9]   Pluripotential melanoblastoma, a unifying concept on malignancies arising in congenital melanocytic nevi: Report of two cases [J].
Cohen, MC ;
Kaschula, ROC ;
SinclairSmith, C ;
Emms, M ;
Drut, R .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (05) :801-812
[10]   MALIGNANT RHABDOID TUMOR OF THE PROSTATIC REGION - IMMUNOHISTOLOGICAL AND ULTRASTRUCTURAL EVIDENCE FOR EPITHELIAL ORIGIN [J].
EKFORS, TO ;
AHO, HJ ;
KEKOMAKI, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1985, 406 (03) :381-388